58 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 58 of 58 clinical reviews.
Complete guide to isotretinoin dosing for adults aged 30 to 49, covering starting doses, cumulative targets, dose adjustments, iPLEDGE requirements, and what to expect during a course of treatment.
A clinician-level review of isotretinoin use after bariatric surgery, covering altered absorption, dosing adjustments, iPLEDGE requirements, lipid monitoring, and case-specific considerations for Roux-en-Y and sleeve gastrectomy patients.
A clinician-level review of how isotretinoin affects appetite, hunger hormones, blood sugar, and food cravings, with primary-literature citations and practical management guidance.
A physician-level review of isotretinoin's autoimmune effects: documented risks, mechanistic evidence, monitoring protocols, and clinical decision-making for patients with pre-existing autoimmune conditions.
A board-reviewed, primary-literature analysis of every cancer signal linked to isotretinoin: skin malignancy, colorectal cancer, hematologic risk, and the protective data. Includes FDA labeling, trial citations, and clinical guidance.
A thorough clinical review of isotretinoin's effects on cognition, mood, and brain function, covering mechanisms, trial data, depression risk, and what patients and prescribers need to know.
Evidence-based guide to every clinically significant isotretinoin drug interaction, including tetracyclines, methotrexate, vitamin A, hormonal contraceptives, and CYP-mediated interactions.
Compare isotretinoin (Accutane) pricing against oral antibiotics, spironolactone, hormonal therapy, and other acne treatments with trial-level efficacy data.
Evidence-based isotretinoin dosing guidance for adults aged 50 to 64, covering starting doses, cumulative targets, lipid monitoring, drug interactions, and perimenopause or andropause considerations.
Evidence-based guide to isotretinoin dose adjustment in patients with kidney disease, including pharmacokinetic data, monitoring protocols, and clinical recommendations for renal impairment.
Foods to avoid on Accutane: alcohol adds liver stress, liver meat more than weekly needs monitoring, and large grapefruit intake may raise drug levels.
A clinical review of isotretinoin pipeline developments, novel formulations, topical retinoid advances, and next-generation acne therapies that may reshape severe acne treatment.
A clinician-focused guide to isotretinoin dosing in adults aged 65 and older, covering dose selection, cumulative targets, renal and hepatic adjustments, drug interactions, and iPLEDGE requirements specific to older patients.
How to safely monitor patients aged 65 and older on isotretinoin for severe acne. Covers labs, fracture risk, psychiatric screening, drug interactions, and deprescribing considerations backed by primary clinical evidence.
A comprehensive, evidence-based review of isotretinoin's effects on hair and skin, including dryness, telogen effluvium, barrier disruption, and long-term outcomes, with primary-literature citations throughout.
Evidence-based guide to prescribing isotretinoin in organ transplant recipients, people living with HIV, autoimmune disease patients, and other special populations. Covers dosing adjustments, monitoring protocols, and risk-benefit analysis with cited clinical data.
A guide to how isotretinoin affects liver enzymes, triglycerides, and hepatic function, including monitoring protocols, dose adjustments, and when to stop treatment.
How the U.S. isotretinoin market works today, which brands remain available, how iPLEDGE affects dispensing, and how to verify a real shortage.
Missing a day of Accutane won't derail treatment. Isotretinoin works by cumulative dose. Take it with a fatty meal if your next dose is 6 to 8 hours away.
Fasting before isotretinoin lab work: a 12-hour fast is standard before lipid panels for accurate triglyceride and LDL readings. Water and meds are fine.
Complete isotretinoin monitoring schedule with lab tests, exam timelines, and clinical checkpoints. Evidence-based guidance for baseline, monthly, and post-treatment monitoring on Accutane.
A guide to preserving muscle mass and function during isotretinoin therapy, covering myotoxicity mechanisms, creatine kinase monitoring, exercise modifications, and nutritional protocols backed by primary literature.
A clinician-grade review of isotretinoin's off-label applications beyond severe acne, including rosacea, hidradenitis suppurativa, neuroblastoma, and photoaging, with evidence levels for each use.
A board-reviewed guide to isotretinoin monitoring in adults aged 50 to 64, covering labs, cardiovascular risk, drug interactions, iPLEDGE requirements, and dose adjustments for perimenopause and andropause.
What to report after an extra isotretinoin dose, when to seek emergency help, and why treatment doses and half-lives do not establish safe overdose limits.
A deep dive into isotretinoin's patent history, generic entry timeline, mechanism of action, and what the loss of brand exclusivity means for patients today.
A board-reviewed, MD-level guide to isotretinoin pharmacokinetics covering absorption, protein binding, CYP metabolism, active metabolites, half-life, and clinical implications for dosing and iPLEDGE requirements.
Evidence-based guidance on how long to hold isotretinoin before surgery, dermabrasion, laser, and other procedures, with primary-literature citations and physician commentary.
An evidence-based guide to isotretinoin teratogenicity, iPLEDGE requirements, contraceptive mandates, and lactation data, with PubMed and FDA citations throughout.
A deep review of isotretinoin real-world evidence from patient registries, claims databases, and post-marketing surveillance. Covers relapse rates, safety signals, iPLEDGE data, and how RWE complements the original clinical trials.
A clinical guide to isotretinoin (Accutane) safety in young adults aged 18-29, covering side effects, monitoring protocols, mental health screening, iPLEDGE requirements, and fertility considerations.
Review isotretinoin treatment after age 65, including medication interactions, formulation instructions, lab monitoring, eye and bone health, and iPLEDGE access.
A guide to isotretinoin safety for adults aged 50 to 64, covering cardiovascular risks, lipid monitoring, iPLEDGE requirements, drug interactions, and dosing strategies backed by published trial data.
FDA's isotretinoin label warns of pseudotumor cerebri and says concomitant tetracyclines should be avoided, since both classes raise intracranial pressure.
A clinician-level guide to how season, UV exposure, temperature, and humidity affect isotretinoin therapy. Covers sun protection protocols, winter dryness management, cumulative dosing strategy, and iPLEDGE compliance across the calendar year.
Compare isotretinoin storage labels, capsule colors and expiration dates. Learn what to record when a delivery gets hot and how to assess a damaged package.
Complete dosing guide for isotretinoin (Accutane) in young adults aged 18 to 29, including weight-based protocols, cumulative dose targets, side effect management, and fertility considerations.
A complete history of isotretinoin (Accutane), from its synthesis as a vitamin A derivative in the 1960s through FDA approval in 1982, the iPLEDGE program, and modern generic formulations.
Large studies show no clear causal link between Accutane and depression, but FDA requires monthly mood screening. See the research and warning signs.
Isotretinoin causes sebocyte apoptosis, cuts sebum up to 90%, normalizes keratinization and lowers TLR-2, IL-1a, IL-6, TNF-a, explaining 85% remission rates.
Isotretinoin monitoring for ages 30-49 means monthly CBC, lipid panel, LFTs and mental health checks under iPLEDGE. See what each result should look like.
Keep final-dose dates, safety follow-up, and acne observations separate after isotretinoin, with clear context for relapse research and procedures.
A detailed guide to Aetna (CVS Health) coverage for isotretinoin (Accutane), including prior authorization criteria, step therapy requirements, formulary tier, appeal strategies, and out-of-pocket cost estimates.
A detailed guide to Anthem (Elevance Health) coverage for isotretinoin (Accutane), including prior authorization criteria, formulary tier, step therapy requirements, and how to appeal a denial.
A guide to BCBS Federated coverage of isotretinoin, including prior authorization criteria, formulary tiers, step therapy requirements, appeal strategies, and cost benchmarks.
A clinical guide to Cigna's isotretinoin coverage: formulary tier, prior authorization criteria, step therapy requirements, appeal strategies, and real out-of-pocket costs for 2024.
Find out whether Humana covers isotretinoin (Accutane) for severe acne, including formulary tier placement, prior authorization criteria, step therapy rules, and how to appeal a denial.
A detailed guide to Kaiser Permanente's formulary status, prior-authorization criteria, step-therapy requirements, and appeal process for isotretinoin (Accutane), with real costs and clinical context.
A detailed guide to Medicare Advantage coverage, formulary placement, prior authorization, step therapy, and appeal strategies for isotretinoin (Accutane), prepared by the HealthRX.com Editorial Team.
A state-by-state breakdown of Medicaid coverage for isotretinoin (Accutane), including prior authorization criteria, step therapy requirements, formulary tiers, appeal pathways, and what to do when coverage is denied.
A complete guide to TRICARE coverage for isotretinoin (Accutane): formulary status, prior authorization criteria, step therapy requirements, appeal steps, and out-of-pocket cost data for 2024 to 2025.
A detailed guide to UnitedHealthcare coverage, prior authorization requirements, formulary tier, step therapy, and appeal strategies for isotretinoin (Accutane) in 2024.
FDA labeling flags dyslipidemia risk for adults 30-49 on isotretinoin; monitor fasting triglycerides alongside liver enzymes during 16-24 week course.
Isotretinoin is not a controlled substance but is prescription-only with mandatory pregnancy-prevention programs like iPLEDGE, PPP, and Healthy Skin worldwide.
Isotretinoin (Accutane) is an oral capsule, not an injectable medication. Learn the correct administration technique, dosing protocols, absorption requirements, and iPLEDGE compliance steps for safe isotretinoin therapy.
FDA label sets no dose adjustment for hepatic impairment. Start 0.5 mg/kg/day, check LFTs baseline and every 4 weeks, stop if ALT/AST exceed 3x ULN.
A clinical deep-dive into how CYP450 polymorphisms, retinoid receptor variants, and lipid metabolism genes influence isotretinoin efficacy, side effects, and dosing.
Evidence-based guide to switching from oral antibiotics, topical retinoids, or hormonal therapy to isotretinoin, and transitioning off isotretinoin to maintenance regimens.